At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 8 enrolled
Drug / intervention
CorPath 200 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CorPath™ 200 System: Coronary Remote Catheterization Feasibility Study
In Brief
A Phase 2 clinical trial evaluating CorPath 200 for Coronary Artery Disease. Completed, enrolled 8 participants across 1 site.
Detailed Summary
An open-label, prospective, single-arm study is designed to evaluate safety, clinical and technical efficacy of the CorPath 200 System in delivery and manipulation of the coronary guide wires and balloon/stent systems for use in robotically-assisted, percutaneous coronary intervention (PCI) procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesColombia
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2010
First PostedFeb 2010
Primary CompletionMay 2010
TodayJul 2026
First PostedFeb 25, 2010
Enrollment StartFeb 1, 2010
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.4 years ago
Interventions
CorPath 200device
CorPath™ 200 robotically-assisted percutaneous coronary intervention
CorPath 200device
CorPath PCI - robotic-assisted percutaneous coronary intervention